Easterly Government Properties reported Q4 FY2025 net income of USD 4.8 million (USD 0.10 per diluted share) and Core FFO of USD 36.8 million (USD 0.77 per diluted share). Q4 total revenues were USD 87.04 million. For FY2025, net income was USD 13.6 million (USD 0.29 per diluted share) and Core FFO was USD 140.1 million (USD 2.99 per diluted share), on total revenues of USD 336.1 million. During FY2025, Easterly completed acquisitions of three properties for an aggregate contractual purchase price of USD 169.9 million and sold ICE - Otay for net sale proceeds of about USD 3.5 million. The company completed the development of an FDA laboratory in Atlanta (revenue commenced with the GSA on Dec. 15, 2025), acquired land for two development projects (a 40,035 square foot federal courthouse in Medford, Oregon and an approximately 64,000 square foot laboratory in Fort Myers, Florida), and maintained a portfolio of 103 operating properties totaling about 10.4 million leased square feet as of Dec. 31, 2025, with a weighted average remaining lease term of 9.5 years. Easterly issued USD 125 million of fixed-rate senior unsecured notes (weighted average maturity 6.6 years; weighted average interest rate 6.29%) and ended 2025 with total indebtedness of about USD 1.7 billion (weighted average interest rate 4.6%). The board approved a Q4 dividend of USD 0.45 per share, payable March 19, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Easterly Government Properties Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260223448140) on February 23, 2026, and is solely responsible for the information contained therein.